Skip to content
Tech Science Daily News
DST Systems completes acquisition of Wealth Management Systems
August 23, 2015
DST Systems, Inc.
NW Bio’s DCVax-L Phase III trial ongoing for treatment of patients with newly diagnosed GBM
MTG Biotherapeutics’ MTG-201 granted FDA Orphan Drug Designation for malignant mesothelioma treatment
You May Also Like
‘Risky’ school playgrounds increase children’s happiness
April 26, 2017
Engineers 3D print the electromagnets at the heart of many electronics
February 23, 2024
Vast Majority of Poor, Urban Women Don’t Use Prenatal Vitamins Before Pregnancy, Study Shows
May 27, 2018